ARAB, Anas, Jana RUDÁ, Alžběta MINSTEROVÁ, Eva DRAŽANOVÁ, Nikoletta SZABÓ, Zenon STARČUK, Irena REKTOROVÁ and Amit Suresh KHAIRNAR. Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease. Neurotoxicity research. New York: Springer, 2019, vol. 36, No 4, p. 724-735. ISSN 1029-8428. Available from: https://dx.doi.org/10.1007/s12640-019-00068-0.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease.
Name in Czech Změny zobrazování kurtózy difúze v metamfetaminem indukovaném myším modelu Parkinsonovy menoci.
Authors ARAB, Anas (760 Syrian Arab Republic, belonging to the institution), Jana RUDÁ (203 Czech Republic, guarantor, belonging to the institution), Alžběta MINSTEROVÁ (203 Czech Republic, belonging to the institution), Eva DRAŽANOVÁ (203 Czech Republic, belonging to the institution), Nikoletta SZABÓ (348 Hungary, belonging to the institution), Zenon STARČUK (203 Czech Republic), Irena REKTOROVÁ (203 Czech Republic, belonging to the institution) and Amit Suresh KHAIRNAR (356 India, belonging to the institution).
Edition Neurotoxicity research, New York, Springer, 2019, 1029-8428.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.992
RIV identification code RIV/00216224:14110/19:00110693
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s12640-019-00068-0
UT WoS 000494483100008
Keywords in English Behaviour; Diffusion kurtosis imaging; MRI; Methamphetamine; Mice; Parkinson’s disease; Tract-based spatial statistics
Tags 14110516, CF MAFIL, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 11/5/2020 10:00.
Abstract
Methamphetamine (METH) abuse is known to increase the risk of Parkinson's disease (PD) due to its dopaminergic neurotoxicity. This is the rationale for the METH model of PD developed by toxic METH dosing (10 mg/kg four times every 2 h) which features robust neurodegeneration and typical motor impairment in mice. In this study, we used diffusion kurtosis imaging to reveal microstructural brain changes caused by METH-induced neurodegeneration. The METH-treated mice and saline-treated controls underwent diffusion kurtosis imaging scanning using the Bruker Avance 9.4 Tesla MRI system at two time-points: 5 days and 1 month to capture both early and late changes induced by METH. At 5 days, we found a decrease in kurtosis in substantia nigra, striatum and sensorimotor cortex, which is likely to indicate loss of DAergic neurons. At 1 month, we found an increase of kurtosis in striatum and sensorimotor cortex and hippocampus, which may reflect certain recovery processes. Furthermore, we performed tract-based spatial statistics analysis in the white matter and at 1 month, we observed increased kurtosis in ventral nucleus of the lateral lemniscus and some of the lateral thalamic nuclei. No changes were present at the early stage. This study confirms the ability of diffusion kurtosis imaging to detect microstructural pathological processes in both grey and white matter in the METH model of PD. The exact mechanisms underlying the kurtosis changes remain to be elucidated but kurtosis seems to be a valuable biomarker for tracking microstructural brain changes in PD and potentially other neurodegenerative disorders.
Links
EF16_013/0001775, research and development projectName: Modernizace a podpora výzkumných aktivit národní infrastruktury pro biologické a medicínské zobrazování Czech-BioImaging
LM2015062, research and development projectName: Národní infrastruktura pro biologické a medicínské zobrazování
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1550/2018, interní kód MUName: Farmakologický výzkum v oblasti farmakokinetiky, neuropsychofarmakologie a onkologie
Investor: Masaryk University, Category A
ROZV/24/LF/2018, interní kód MUName: LF - Příspěvek na IP 2108
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
PrintDisplayed: 26/4/2024 05:02